Neglected Diseases and Drug Discovery: Rsc
There are ~8 million deaths every year from neglected tropical diseases (NTDs) in the underdeveloped world, whilst drug discovery focus and practice is only recently taking on greater urgency and embracing the latest technologies. The aim of this book is to present a state-of-the-art review of drug discovery in respect of NTDs and to highlight best practice to guide ongoing drug discovery effort, to raise awareness and promote debate in neglected disease areas that still have unmet medical need. Neglected Diseases and Drug Discovery, details nearly all of the key diseases that fall into this class. It sets out to make a critical appraisal of…
Mehr
CHF 208.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V105:
Folgt in ca. 15 Arbeitstagen
Produktdetails
Weitere Autoren: Wells, Timothy N. C. (Hrsg.)
- ISBN: 978-1-84973-192-8
- EAN: 9781849731928
- Produktnummer: 11998022
- Verlag: Royal Society Of Chemistry
- Sprache: Englisch
- Erscheinungsjahr: 2011
- Seitenangabe: 438 S.
- Masse: H24.1 cm x B16.2 cm x D2.9 cm 821 g
- Reihenbandnummer: 14
- Gewicht: 821
Über den Autor
Michael J Palmer is a Senior Principal Scientist at Pfizer. He has worldwide medicinal chemistry and drug discovery based experience across many different therapeutic areas. He is a member of the drug discovery teams responsible for carduraTM, additional cardiovascular agents that progressed to man, and cardiovascular and antiviral agents in Phase I and II stages of development. Timothy NC Wells is Chief Scientific Officer at Medicines for Malaria Venture, Geneva, Switzerland.
Bewertungen
Anmelden